Wird geladen...
Gene and protein therapies utilizing VEGF for ALS
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that is usually fatal within 2–5 years. Unfortunately, the only treatment currently available is riluzole, which has a limited efficacy. As a redress, there is an expanding literature focusing on other potential treatment...
Gespeichert in:
| Veröffentlicht in: | Pharmacol Ther |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4659499/ https://ncbi.nlm.nih.gov/pubmed/24177067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2013.10.009 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|